DOE SBIR/STTR for Academic Researchers: Topics, Award Sizes and How to Apply

What Changed With DOE SBIR in 2026

SBIR and STTR authority lapsed for a stretch before Congress reauthorized the programs in April 2026. Secondary sources describe an extension running to 2031, but the exact statutory details differ from one summary to the next, so check the agency's own pages before you build a plan around any single claim. What I can say with more confidence is that DOE restarted its solicitations afterward, and the program is now run out of DOE's Office of Technology Commercialization.

That reorganization matters for applicants. Older advice about DOE SBIR, including a lot of what you'll find in university research-office PDFs, was written for the earlier structure with two annual releases through the Office of Science and other program offices. If a guide mentions a Letter of Intent and a fixed January or June deadline, treat it as historical until you've confirmed it against the current announcement.

The Fall 2026 Phase I Topics and the December 16 Pitch Date

DOE announced its Fall 2026 SBIR/STTR Phase I topics with more than $200 million in federal funding attached to the release. Applicants are asked to submit a pitch by December 16, 2026 through the DOE SBIR/STTR Application Hub. That's about six weeks from today, which is tight if you don't yet have a company, a SAM.gov registration, or a topic in mind.

The pitch-first structure will feel familiar if you read our piece on the NSF Project Pitch step. A short description goes in early, program staff signal whether a full proposal fits, and only then do you invest weeks in the long document. I don't know the exact pitch length limits or the invitation timeline for this release, so read the topic document itself instead of trusting my summary.

Topics are defined by DOE. That's the biggest difference from NIH, where an investigator-initiated idea can fit a broad parent notice. At DOE you choose from a published list, and your product has to answer the specific need written there.

DOE SBIR Award Size: Why the Numbers Don't Agree

If you search for DOE Phase I amounts, you'll find answers ranging from about $200,000 for a nine-month feasibility study to figures near $275,000 over six to twelve months. One listing for a particular DOE release describes a total pool and an expected number of awards, which implies roughly $250,000 per company, while noting that no per-award floor or ceiling had been published. Those are third-party summaries, and they likely describe different releases.

My advice is to ignore every aggregator figure when you build a budget and use the number in the topic you're applying to. Also watch out for a trap I've seen with the NSF numbers circulating this year: a dollar amount quoted in a blog post can belong to a different agency. Phase II amounts are even less settled, and I wouldn't plan around any figure until DOE publishes the Phase II invitation terms.

Is DOE SBIR a Fit for an Academic Biomedical Lab?

Be honest about this one. DOE funds energy, climate, materials, computing, fusion, nuclear, and increasingly AI and autonomous-lab work. Pure clinical products don't belong here. But biotechnology has a real foothold through bioenergy, biomanufacturing, sensors, imaging instruments, isotopes, and data infrastructure. If your lab built a high-throughput measurement tool or a machine-learning pipeline that happens to serve a DOE topic, it's worth reading the list.

The structural rule is that SBIR goes to a for-profit small business. A professor can't apply as the applicant from the university. In an SBIR, the principal investigator usually needs their primary employment with the small business at the time of award, which is a hard constraint for faculty with full-time appointments. STTR is the more natural route for academics: the small business partners formally with a research institution, and that institution must perform a minimum share of the work. Confirm the exact percentages and PI employment rules in the current solicitation, since both have shifted over the years.

Before you invest, talk to your tech transfer office. Intellectual property that the university owns has to be licensed or optioned to the company, and that negotiation can easily take longer than six weeks.

How to Apply to DOE SBIR/STTR

Work backward from the pitch. First, form or identify the small business and complete the federal registrations that every SBIR agency requires, including SAM.gov and the SBA company registry. SAM.gov activation can take weeks, so start it today even if you're unsure about the topic. Second, read the full list of Fall 2026 topics and shortlist two. Third, draft a one-page technical and commercial case: the DOE need, your innovation, the evidence that it could work, and who would buy it.

Reviewers of SBIR proposals care about commercialization in a way that NIH study sections often don't. Name a customer segment, an adoption barrier, and a path past Phase I. A strong scientific story with a vague market section is the most common weakness I see in academic spinouts, and DOE topics are written around a specific problem, so a generic pitch stands out for the wrong reason.

DOE vs NIH Small Business Funding

If your product is a health technology, NIH is almost always the better first stop. Our guides to NIH Phase I and Phase II cover the mechanics. NIH study sections understand clinical translation, and the institutes publish their own interests. DOE makes sense when the application area is energy, environment, or instrumentation, or when the same platform serves both a biomedical market and a DOE mission.

Don't submit the same work to two agencies and hope. Agencies expect disclosure of overlapping proposals, and duplicate funding isn't allowed. If one platform could serve both, write distinct aims for each and tell each program officer what you've submitted elsewhere.

Frequently Asked Questions